Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Newell

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Diabetes Research and Clinical Practice|February 13, 2013
Group follow-up compared to individual clinic visits after structured education for type 1 diabetes: a cluster randomised controlled trialSean F Dinneen, Mary Clare O'Hara, Molly Byrne, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-upAndrea M Isidori, Gregory A Kaltsas, Carlotta Pozza, et al.
BMJ Open|June 26, 2016
Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling interventionPatrick J Murphy, Jenny Mc Sharry, Dympna Casey, et al.
Endocrine Journal|October 16, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 31, 2019
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary carePeter Hayes, Monica Casey, Liam G Glynn, et al.
Clinical Endocrinology|August 30, 2019
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension studyMaria Fleseriu, Stephan Petersenn, Beverly M K Biller, et al.
Clinical Endocrinology|February 19, 2014
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III studyRosario Pivonello, Stephan Petersenn, John Newell-Price, et al.
BMJ Open Respiratory Research|October 27, 2017
Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25-75/FVC) in COPDEric Abston, Alejandro Comellas, Robert Michael Reed, et al.
Journal of the Endocrine Society|November 29, 2024
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free CortisolJohn Newell-Price, Maria Fleseriu, Rosario Pivonello, et al.
Molecular Nutrition & Food Research|March 6, 2008
N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory responseTimo M Buetler, Estelle Leclerc, Alexandra Baumeyer, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Diabetes Research and Clinical Practice|February 13, 2013
Group follow-up compared to individual clinic visits after structured education for type 1 diabetes: a cluster randomised controlled trialSean F Dinneen, Mary Clare O'Hara, Molly Byrne, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-upAndrea M Isidori, Gregory A Kaltsas, Carlotta Pozza, et al.
BMJ Open|June 26, 2016
Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling interventionPatrick J Murphy, Jenny Mc Sharry, Dympna Casey, et al.
Endocrine Journal|October 16, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 31, 2019
Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary carePeter Hayes, Monica Casey, Liam G Glynn, et al.
Clinical Endocrinology|August 30, 2019
Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension studyMaria Fleseriu, Stephan Petersenn, Beverly M K Biller, et al.
Clinical Endocrinology|February 19, 2014
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III studyRosario Pivonello, Stephan Petersenn, John Newell-Price, et al.
BMJ Open Respiratory Research|October 27, 2017
Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25-75/FVC) in COPDEric Abston, Alejandro Comellas, Robert Michael Reed, et al.
Journal of the Endocrine Society|November 29, 2024
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free CortisolJohn Newell-Price, Maria Fleseriu, Rosario Pivonello, et al.
Molecular Nutrition & Food Research|March 6, 2008
N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory responseTimo M Buetler, Estelle Leclerc, Alexandra Baumeyer, et al.
Pageof 22